Resources Contact Us Home
Browse by: INVENTOR PATENT HOLDER PATENT NUMBER DATE
 
 
Inventor:
Hamori; Tamas
Address:
Budapest, HU
No. of patents:
22
Patents:




Patent Number Title Of Patent Date Issued
6858605 Substituted 2,3-benzodiazepine derivatives February 22, 2005
The invention relates to new 2,3-benzodiazepine derivatives of formula (I), isomers and acid addition salts thereof and to pharmaceutical compositions containing the same, as well as to pharmaceutical compositions and methods of using the same suitable for treating conditions associated
6600036 Condensed 2,3-benzodiazepine derivatives and their use as AMPA-receptor inhibitors July 29, 2003
Compounds of formula I are described, their production and use in pharmaceutical agents. ##STR1##
6482819 2,3-benzodiazepine derivatives November 19, 2002
2,3-Benzodiazepines of formula (I), their stereoisomers and acid addition salts, ##STR1##wherein the variables have the meaning given in the specification, and pharmaceutical compositions containing them which are suitable for treating conditions associated with muscle spasms, epilep
6323197 Condensed 2,3-benzodiazepine derivatives and their use as AMPA-receptor inhibitors November 27, 2001
The invention concerns compounds of formula (I), in which R.sup.1, R.sup.2, R.sup.3 and R.sup.4 mean hydrogen or different substituents; X means hydrogen or halogen; Y means C.sub.1-6 alkoxy or X and Y together mean --O--(CH.sub.2).sub.n --O--; n means 1, 2 or 3; and A together with
6200970 2,3-benzodiazepine derivatives and their use as AMPA-receptor inhibitors March 13, 2001
A compound of formula I ##STR1##in whichX means hydrogen or halogen,Y means --NR.sup.3 -- or --N.dbd.,R.sup.1 and R.sup.2 are the same or different and mean hydrogen, C.sub.1 -C.sub.6 alkyl, nitro, halogen, the group --NR.sup.8 R.sup.9, --O--C.sub.1-4 alkyl, --CF.sub.3, OH or C.sub.1-6 a
6075018 1-[2-(substituted vinyl)]-3,4-dihydro-4-dihydro-5H-2,3-benzodiazepine derivatives June 13, 2000
The invention relates to new 1-[2-(substituted vinyl)]-3,4-dihydro-5H-2,3-benzodiazepine derivatives, a process for the preparation thereof and pharmaceutical compositions comprising them. The new 1-[2-(substituted vinyl)]-3,4-dihidro-5H-2,3-benzodiazepine derivatives according to th
5942506 1-[2-(substituted vinyl)]-5H-2,3-benzodiazepine derivatives August 24, 1999
This invention relates to new 1-[2-(substituted vinyl)]-5H-2,3-benzodiazepine derivatives, a process for the preparation thereof, pharmaceutical compositions comprising the same, to the use of the said benzodiazepine derivatives for the treatment of diseases and for the preparation o
5807851 2,3-Benzodiazepine Derivatives as non-competitive AMPA September 15, 1998
Derivatives of 2,3-benzodiazepine are substituted by one or two halogen atom(s) and have the general formula ##STR1## These derivatives are non-competitive AMPA antagonists and are used in pharmaceutical compositions. A process to make the 2,3-benzodiazepine derivatives includes
5756495 3-substituted 3H-2, 3-benzodiazepine derivatives, the production and use as pharmaceutical agent May 26, 1998
New 3-substituted 3H-2,3-benzodiazepine derivatives of general formula I ##STR1## in which R.sup.1, R.sup.2, R.sup.3, R.sup.4, R.sup.5, R.sup.6, R.sup.7 and n have the meanings indicated in the description, their production as well as their use as pharmaceutical agents are described.
5639751 N-acyl-2,3-benzodiazepine derivatives for treating acute and chronic neurodegenerative disorders June 17, 1997
The invention relates to novel N-acyl-2,3-benzodiezapine derivatives of the general formula (I), their stereoisomers and acid-addition salts, pharmaceutical compositions containing them and a process for their preparation. In the general formula (I)R stands for a C.sub.1-6 alkanoyl group
5604223 N acyl 2 3 benzodiazepine derivatives pharmaceutical compositions containing them and process fo February 18, 1997
The invention relates to novel N-acyl-2,3-benzodiazepine derivatives of the general formula (I), their stereoisomers and acid-addition salts, pharmaceutical compositions containing them and a process for their preparation. In the general formula (I), defined in this specification, a
5536832 N-acyl-2,3-benzodiazepine derivatives pharmaceutical compositions containing them and process fo July 16, 1996
The invention relates to novel N-acyl-2,3-benzodiezapine derivatives of the general formula (I), their stereoisomers and acid-addition salts, pharmaceutical compositions containing them and a process for their preparation. In the general formula (I)R stands for a C.sub.1-6 alkanoyl group
5521174 N-acyl-2,3-benzodiazepine derivatives and a method of treating spasms of the skeletal musculatur May 28, 1996
The invention relates to novel N-acyl-2,3-benzodiezapine derivatives and a method of treating spasms of the skeletal musculature therewith.
5519019 N-acyl-2,3-benzoidazepine derivatives, pharmaceutical compositions containing them and process f May 21, 1996
The invention relates to novel N-acyl-2,3-benzodiezapine derivatives of the general formula (I), their stereoisomers and acid-addition salts, pharmaceutical compositions containing them and a process for their preparation. In the general formula (I)R stands for a C.sub.1-6 alkanoyl group
5459137 N-acyl-2,3-benzodiazepine derivatives, pharmaceutical compositions containing them and process f October 17, 1995
The invention relates to novel N-acyl-2,3-benzodiezapine derivatives of the general formula (I), their stereoisomers and acid-addition salts, pharmaceutical compositions containing them and a process for their preparation. In the general formula (I), defined in the specification, a m
5288863 Process for the preparation of high-purity 1-(3-chloro-phenyl)-4-methyl-7,8-dimethoxy-5H-2,3-ben February 22, 1994
The invention relates to a process for the preparation of 1-(3-chlorophenyl)-4-methyl-7,8-dimethoxy-5 H-2,3-benzodiazepine of formula (I) ##STR1## in high purity and in a quality suitable for pharmaceutical purposes. According to the invention the reaction of 1 mole of 2-acet
5204343 5H-benzodiazepin derivative April 20, 1993
The invention relates to the new 1-(3-chlorophenyl)-4-hydroxymethyl-7,8-dimethoxy-5H-2,3-benzodiazepine of formula (I) ##STR1## and pharmaceutically acceptable acid addition salts thereof, furthermore to a process for preparing these compounds.The compounds according to the inven
4840948 1-(hydroxystyrl)-5H-2,3-benzodiazepine derivatives, and pharmaceutical compositions containing t June 20, 1989
This invention relates to new 1-(hydroxystyryl)-5H-2,3-benzodiazepine derivatives of the general formula (I) and to a process for the preparation thereof, furthermore to pharmaceutical compositions containing the same, ##STR1## wherein R stands for a hydrogen or halogen atom, or
4835152 1-(4-Aminophenyl)-4-methyl-7,8-methylenedioxy-3,4-dihydro-5H-2,3-b enzodiazepine and acid additio May 30, 1989
The invention relates to new 1-(4-aminophenyl)-4-methyl-7,8-methylenedioxy-3,4-dihydro-5H-2,3-benzodiaz epi ne of formula (1), optically active isomers and acid addition salts thereof as well as to pharmaceutical compositions containing these compounds. ##STR1## The new compou
4785104 3-(hydroxymethyl)-isoquinoline derivatives November 15, 1988
This invention relates to new 3-(hydroxymethyl)-isoquinoline derivatives of the general formula (I), their acid addition salts, and to a process for the preparation thereof, furthermore to pharmaceutical compositions containing the same, ##STR1## wherein R and R.sup.1 are identic
4614740 5H-2,3-benzodiazepine derivatives and pharmaceutical compositions containing the same September 30, 1986
The invention relates to new 5H-2,3-benzodiazepine derivatives and a process for the preparation thereof, furthermore to pharmaceutical compositions containing the same.The new 5H-2,3-benzodiazepine derivatives of the invention possess valuable central nervous effect and in particular ex
4423044 3,4-Dihydro-5H-2,3-benzodiazepine derivatives and pharmaceutical use thereof December 27, 1983
The invention relates to new 3,4-dihydro-5H-2,3-benzodiazepine derivatives of general formula (I) and pharmaceutically acceptable acid addition salts thereof, ##STR1## wherein R represents a phenyl group optionally carrying one or two substituents selected from the group consisti


 
 
  Recently Added Patents
Low blur molecular resist
Heat recycling system with nighttime cooling recovery
Method and apparatus for k-space and hybrid-space based image reconstruction for parallel imaging and artifact correction
Method and system for automated medical records processing
Safety guard for power take off
X-ray system with an adjustment-acquisition device
Genetic inhibition by double-stranded RNA
  Randomly Featured Patents
Suction device used for internal combustion engine
Apparatus for increasing the input noise margin of a gate
Production of maleic anhydride
Motor vehicle door comprising an insulating element
Direct reading reactance meter
Equipment for UV wafer heating and photochemistry
Method for determining combination of data for transfer, and combination determining circuit
File managing system, file management apparatus, file management method, and program storage medium
Method and system for curing an ultra-violet curable sealant that is shadowed by metallization
Method and device for printing a web or a rectangular piece of material